A patient-completed and optically read data acquisition system for clinical trials

被引：4

作者：

Quan, Hue ^{[1
]}

Biondo, Patricia D. ^{[2
]}

Stiles, Carla ^{[2
]}

Moulin, Dwight E. ^{[3
]}

Hagen, Neil A. ^{[2
,4
]}

机构：

[1] Alberta Hlth Serv, Reg Palliat Care Program, Edmonton, AB, Canada

[2] Tom Baker Canc Clin, Alberta Hlth Serv, Calgary, AB, Canada

[3] Univ Western Ontario, London Reg Canc Program, Clin Neurol Sci & Oncol, London, ON, Canada

[4] Univ Calgary, Div Palliat Med, Calgary, AB, Canada

来源：

CONTEMPORARY CLINICAL TRIALS | 2011年 / 32卷 / 02期

基金：

加拿大健康研究院;

关键词：

Data collection; Teleform; Optical character recognition-based technology; Clinical trial; DATA-ENTRY; RESEARCH NETWORK; IMPLEMENTATION; TELEFORM(TM); TECHNOLOGY; COLLECTION; FORMS; PAIN;

D O I：

10.1016/j.cct.2010.12.004

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Data collection and management within multicentre clinical trials can be challenging. We describe an adaptation of Teleform (R) technology to enable data recording by patients and their families on teleforms faxed and optically read directly into an electronic database, eliminating the need for case report forms. Preliminary results from a modest study sample size support the use of optically read forms for data collection by patients and their families, requiring only a pen, paper, and fax machine at participating sites. (C) 2010 Elsevier Inc. All rights reserved.

引用

页码：173 / 177

页数：5

共 32 条

[31] Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial Fibrillation
Patel, Siddharth M.
Braunwald, Eugene
Steffel, Jan
Boriani, Giuseppe
Palazzolo, Michael G.
Antman, Elliott M.
Bohula, Erin A.
Carnicelli, Anthony P.
Connolly, Stuart J.
Eikelboom, John W.
Gencer, Baris
Granger, Christopher B.
Morrow, David A.
Patel, Manesh R.
Wallentin, Lars
Ruff, Christian T.
Giugliano, Robert P.
CIRCULATION, 2024, 149 (12) : 932 - 943
[32] DISEASE CONTROL RATE AT 9 AND 18 WEEKS AS PRIMARY ENDPOINTS FOR PHASE II CLINICAL TRIALS IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA: AN INDIVIDUAL PATIENT DATA COMBINED ANALYSIS OF 10 EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC) LUNG CANCER GROUP STUDIES.
Greillier, Laurent
Hasan, Baktiar
Baas, Paul
Welch, John
Van Meerbeeck, Jan P.
Gaafar, Rabab M.
Sylvester, Richard
Margerit, Sabine
Lacombe, Denis
O'Brien, Mary
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S406 - S407

← 1 2 3 4 →